These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 3470922

  • 21. Acute myelomonoblastic leukemia in a patient with multiple myeloma.
    Colović M, Jovanović V, Ristić M.
    Acta Med Iugosl; 1989; 43(1):77-82. PubMed ID: 2711863
    [Abstract] [Full Text] [Related]

  • 22. Acute leukemia secondary to multiple myeloma.
    de Gramont A, Rioux E, Shields C.
    Can Med Assoc J; 1983 Sep 15; 129(6):534, 536. PubMed ID: 6576845
    [No Abstract] [Full Text] [Related]

  • 23. [Dhnmics of histological changes in the bone marrow in a patient with multiple myeloma during the process of treatment with sarcolysin].
    Voronin VM, Rybakova ME.
    Probl Gematol Pereliv Krovi; 1969 Feb 15; 14(2):53-6. PubMed ID: 5351088
    [No Abstract] [Full Text] [Related]

  • 24. [Myeloma with extramedullary extension coinciding with the normalization of serum paraproteins after treatment].
    Bernat S, Gozalbo T, García-Boyero R, Guinot M.
    Sangre (Barc); 1998 Feb 15; 43(1):96-7. PubMed ID: 9577192
    [No Abstract] [Full Text] [Related]

  • 25. Epidemic acute leukemia.
    Holland JF.
    N Engl J Med; 1970 Nov 19; 283(21):1165-6. PubMed ID: 5273283
    [No Abstract] [Full Text] [Related]

  • 26. Acute erythroid leukemia after cyclophosphamide therapy for multiple myeloma: report of two cases.
    West WO.
    South Med J; 1976 Oct 19; 69(10):1331-2. PubMed ID: 1068531
    [Abstract] [Full Text] [Related]

  • 27. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
    Oken MM, Harrington DP, Abramson N, Kyle RA, Knospe W, Glick JH.
    Cancer; 1997 Apr 15; 79(8):1561-7. PubMed ID: 9118039
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Multiple myeloma: a case of a cure?
    Robert JL, Tubiana N, Lejeune C, Carcassonne Y.
    Nouv Rev Fr Hematol (1978); 1989 Apr 15; 31(1):35-7. PubMed ID: 2644619
    [Abstract] [Full Text] [Related]

  • 30. Non-secretary multiple myeloma in a young Ethiopian: case report.
    Teklesilassie H, Sherif A, Diro E.
    Ethiop Med J; 2010 Apr 15; 48(2):165-8. PubMed ID: 20608020
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Deletion of 5q31 and 7q31 in patients with stable melphalan treated multiple myeloma.
    Amiel A, Yukla M, Yogev S, Manor Y, Fejgin MD, Lishner M.
    Cancer Genet Cytogenet; 2004 Jul 01; 152(1):84-7. PubMed ID: 15193449
    [Abstract] [Full Text] [Related]

  • 34. Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
    Vigneau C, Ardiet C, Bret M, Laville M, Fiere D, Tranchand B, Fouque D.
    J Nephrol; 2002 Jul 01; 15(6):684-9. PubMed ID: 12495285
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Multiple myeloma terminating in acute eosinophilic leukemia.
    Maeda K, VanSlyck EJ, VanDyke DL.
    Cancer Genet Cytogenet; 1985 Mar 01; 16(1):81-9. PubMed ID: 3971334
    [Abstract] [Full Text] [Related]

  • 37. Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
    Giralt S, Aleman A, Anagnostopoulos A, Weber D, Khouri I, Anderlini P, Molldrem J, Ueno NT, Donato M, Korbling M, Gajewski J, Alexanian R, Champlin R.
    Bone Marrow Transplant; 2002 Sep 01; 30(6):367-73. PubMed ID: 12235521
    [Abstract] [Full Text] [Related]

  • 38. Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
    Palumbo A, Falco P, Corradini P, Falcone A, Di Raimondo F, Giuliani N, Crippa C, Ciccone G, Omedè P, Ambrosini MT, Gay F, Bringhen S, Musto P, Foà R, Knight R, Zeldis JB, Boccadoro M, Petrucci MT, GIMEMA--Italian Multiple Myeloma Network.
    J Clin Oncol; 2007 Oct 01; 25(28):4459-65. PubMed ID: 17785703
    [Abstract] [Full Text] [Related]

  • 39. [Therapy of multiple myeloma].
    La Verde G, Pulsoni A, Petrucci MT, Mandelli F.
    Recenti Prog Med; 1997 Apr 01; 88(4):186-93. PubMed ID: 9206817
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
    Hulin C, Facon T, Rodon P, Pegourie B, Benboubker L, Doyen C, Dib M, Guillerm G, Salles B, Eschard JP, Lenain P, Casassus P, Azaïs I, Decaux O, Garderet L, Mathiot C, Fontan J, Lafon I, Virion JM, Moreau P.
    J Clin Oncol; 2009 Aug 01; 27(22):3664-70. PubMed ID: 19451428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.